title: Successful treatment of stage-IIIB seminoma with single-agent carboplatin therapy.
abstract: Single-agent carboplatin chemotherapy has recently been introduced into the therapy of limited seminoma. Because of poor compliance due to Down's syndrome we successfully treated a 32-year-old man with relapsed stage-IIIB seminoma with a dose-modified carboplatin monotherapy schedule leading to complete remission even after a follow-up of 4 years.
authors.affiliation: Department of Internal Medicine, Katharinenhospital, Stuttgart, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Bohle
authors.forename: U
authors.initials: U
authors.lastname: Ruether
authors.forename: J
authors.initials: J
authors.lastname: Rassweiler
authors.forename: C
authors.initials: C
authors.lastname: Nunnensiek
authors.forename: F
authors.initials: F
authors.lastname: Eisenberger
authors.forename: P
authors.initials: P
authors.lastname: Jipp
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D018239:Seminoma / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D016190:Carboplatin